New research indicates that nicotine-based drugs may help
delay the time that people with dementia enter nursing homes.
Researchers at the King's College London said a new study
on mice was able to demonstrate positive effects. They found mice given
nicotine were able to carry out specified tasks although they were distracted
at the same time.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
Previous studies have shown that nicotine can help in boosting boost learning, memory and attention. Nicotine stimulates flow of the hormone adrenaline in the body and this stimulates the brain, the researchers revealed.
"Nicotine, like many other drugs, has multiple
effects, some of which are harmful, whereas others may be beneficial,"
said lead researcher Professor Ian Stolerman. "It may be possible for
medicinal chemists to devise compounds that provide some of the beneficial
effects of nicotine while cutting out the toxic effects."
The study is due to be presented at the Federation of European Neuroscience Societies conference in Geneva.
Source: Medindia
RAS/L
The study is due to be presented at the Federation of European Neuroscience Societies conference in Geneva.
Source: Medindia
RAS/L
Dyslexia
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.
Advertisement
 Early Alzheimer's Diagnosis, Treatment Possible: StudyCanadian scientists have unearthed clear evidence that increases in the size of the ventricles, fluid-filled cavities in the brain, are directly linked with cognitive impairment and | Advertisement
|
Plant Molecules Could Reduce Intensity of Alzheimer's Disease
Researchers at the University of South Florida and Cedars-Sinai Medical Center have found that two molecules - luteolin and diosmin - found in some plants may have a beneficial effect
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.